Bluebird Bio | Spese Operative

Operating Expenses Cambiamento Data
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Avrobio USD 22.93M 90.94M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Moderna USD 2.8B 1.04B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Bluebird Bio Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.